4-aminopyridine has been researched along with Pulmonary Hypertension in 10 studies
Excerpt | Relevance | Reference |
---|---|---|
"4-Aminopyridine (4-AP) is a recent treatment indicated to improve walking in patient with multiple sclerosis." | 7.91 | Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine. ( Chabot, F; Chaouat, A; Gomez, E; Guillaumot, A; Petitpain, N; Ribeiro Baptista, B; Valentin, S; Yelehé-Okouma, M, 2019) |
"4-Aminopyridine (4-AP) is a recent treatment indicated to improve walking in patient with multiple sclerosis." | 3.91 | Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine. ( Chabot, F; Chaouat, A; Gomez, E; Guillaumot, A; Petitpain, N; Ribeiro Baptista, B; Valentin, S; Yelehé-Okouma, M, 2019) |
"The effects of the outward rectifying potassium channel blocker, 4-aminopyridine, on contractile tone and on contractile responses to the spasmogens, 5-hydroxytryptamine and endothelin-1, were examined in pulmonary arteries (main and intralobar) and systemic vessels (aorta and mesenteric artery) from rats with and without hypoxic pulmonary hypertension." | 3.70 | Functional effects of 4-aminopyridine (4-AP) on pulmonary and systemic vessels from normoxic control and hypoxic pulmonary hypertensive rats. ( Doggrell, SA; Gambino, A; Wanstall, JC, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ribeiro Baptista, B | 1 |
Petitpain, N | 1 |
Gomez, E | 1 |
Yelehé-Okouma, M | 1 |
Valentin, S | 1 |
Guillaumot, A | 1 |
Chabot, F | 1 |
Chaouat, A | 1 |
Antigny, F | 1 |
Chaumais, MC | 1 |
Humbert, M | 1 |
Montani, D | 1 |
Lv, Y | 1 |
Tang, LL | 1 |
Wei, JK | 1 |
Xu, XF | 1 |
Gu, W | 1 |
Fu, LC | 1 |
Zhang, LY | 1 |
Du, LZ | 1 |
Hyvelin, JM | 1 |
Gautier, M | 1 |
Lemaire, MC | 1 |
Bonnet, P | 1 |
Eder, V | 1 |
Olschewski, A | 1 |
Hong, Z | 2 |
Linden, BC | 1 |
Porter, VA | 1 |
Weir, EK | 2 |
Cornfield, DN | 1 |
Brevnova, EE | 1 |
Platoshyn, O | 1 |
Zhang, S | 1 |
Yuan, JX | 1 |
Rezaie-Majd, S | 1 |
Murar, J | 1 |
Nelson, DP | 1 |
Kelly, RF | 1 |
Lang, IM | 1 |
Varghese, A | 1 |
Fike, CD | 1 |
Kaplowitz, MR | 1 |
Zhang, Y | 1 |
Madden, JA | 1 |
Doggrell, SA | 1 |
Wanstall, JC | 1 |
Gambino, A | 1 |
Bonnet, S | 1 |
Dubuis, E | 1 |
Vandier, C | 1 |
Martin, S | 1 |
Marthan, R | 1 |
Savineau, JP | 1 |
10 other studies available for 4-aminopyridine and Pulmonary Hypertension
Article | Year |
---|---|
Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.
Topics: 4-Aminopyridine; Antihypertensive Agents; Dyspnea; Female; Humans; Hypertension, Pulmonary; Middle A | 2019 |
Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.
Topics: 4-Aminopyridine; Humans; Hypertension, Pulmonary; Multiple Sclerosis; Pulmonary Arterial Hypertensio | 2019 |
Decreased Kv1.5 expression in intrauterine growth retardation rats with exaggerated pulmonary hypertension.
Topics: 4-Aminopyridine; Acetylcholine; Animals; Barium Compounds; Cell Hypoxia; Cells, Cultured; Chlorides; | 2013 |
Adaptative modifications of right coronary myocytes voltage-gated K+ currents in rat with hypoxic pulmonary hypertension.
Topics: 4-Aminopyridine; Animals; Coronary Vessels; Hypertension, Pulmonary; Hypoxia; Male; Membrane Potenti | 2009 |
Contribution of the K(Ca) channel to membrane potential and O2 sensitivity is decreased in an ovine PPHN model.
Topics: 4-Aminopyridine; Animals; Animals, Newborn; Disease Models, Animal; Female; Gestational Age; Hyperte | 2002 |
Overexpression of human KCNA5 increases IK V and enhances apoptosis.
Topics: 4-Aminopyridine; Animals; Apoptosis; Blotting, Western; Caspase 3; Caspases; Cells, Cultured; Chloro | 2004 |
Increased release of serotonin from rat ileum due to dexfenfluramine.
Topics: 4-Aminopyridine; Animals; Caffeine; Calcium; Chromatography, High Pressure Liquid; Cytosol; Dexfenfl | 2004 |
Voltage-gated K+ channels at an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets.
Topics: 4-Aminopyridine; Animals; Arterioles; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; In V | 2006 |
Functional effects of 4-aminopyridine (4-AP) on pulmonary and systemic vessels from normoxic control and hypoxic pulmonary hypertensive rats.
Topics: 4-Aminopyridine; Animals; Aorta; Arteries; Endothelin-1; Hypertension, Pulmonary; Hypoxia; In Vitro | 1999 |
Reversal of chronic hypoxia-induced alterations in pulmonary artery smooth muscle electromechanical coupling upon air breathing.
Topics: 4-Aminopyridine; Animals; Blood Pressure; Calcium; Cells, Cultured; Chronic Disease; Electrophysiolo | 2002 |